Hematopoietic stem cell targeting with surface-engineered lentiviral vectors.
Verhoeyen
Els
E
Cosset
François-Loïc
FL
D000818:Animals; D018952:Antigens, CD34 / Q000097:blood; D002460:Cell Line; D019070:Cell Lineage; D002478:Cells, Cultured; D036101:Cord Blood Stem Cell Transplantation / Q000379:methods; D005312:Fetal Blood / Q000166:cytology / Q000378:metabolism; D005818:Genetic Engineering; D005822:Genetic Vectors / Q000235:genetics; D006367:HeLa Cells; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000378:metabolism*; D006801:Humans; D007231:Infant, Newborn; D016086:Lentivirus / Q000235:genetics*; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D019089:Stem Cell Factor / Q000235:genetics; D013926:Thrombopoietin / Q000235:genetics; D014161:Transduction, Genetic / Q000379:methods*
D018952:Antigens, CD34; D019089:Stem Cell Factor; D013926:Thrombopoietin